Symmetrel: Effective Antiviral and Parkinson's Therapy
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.35 | $40.42 (0%) | 🛒 Add to cart |
| 60 | $1.06 | $80.84 $63.64 (21%) | 🛒 Add to cart |
| 90 | $0.97 | $121.26 $87.72 (28%) | 🛒 Add to cart |
| 120 | $0.90 | $161.68 $107.50 (34%) | 🛒 Add to cart |
| 180 | $0.82 | $242.52 $147.06 (39%) | 🛒 Add to cart |
| 270 | $0.77 | $363.78 $208.98 (43%) | 🛒 Add to cart |
| 360 | $0.73
Best per pill | $485.04 $263.16 (46%) | 🛒 Add to cart |
Synonyms | |||
Symmetrel (amantadine hydrochloride) is a well-established antiviral and antiparkinsonian agent with a unique dual mechanism of action. As a synthetic tricyclic amine, it demonstrates clinical efficacy against influenza A virus and provides symptomatic relief in Parkinson’s disease. Its neuroprotective properties and favorable pharmacokinetic profile make it a valuable therapeutic option for appropriate patient populations under expert supervision.
Features
- Contains amantadine hydrochloride as the active pharmaceutical ingredient
- Available in 100 mg capsule and oral syrup formulations
- Exhibits both antiviral and dopaminergic activity
- Demonstrated blood-brain barrier penetration
- Stable shelf life with proper storage conditions
- Multiple manufacturing sources ensuring consistent supply
Benefits
- Provides effective prophylaxis against influenza A virus infection
- Reduces severity and duration of influenza A symptoms when administered early
- Improves Parkinsonian symptoms including rigidity, bradykinesia, and tremor
- Offers alternative therapy for patients experiencing levodopa complications
- May provide neuroprotective effects in neurological conditions
- Generally well-tolerated with manageable side effect profile
Common use
Symmetrel is primarily indicated for the prophylaxis and treatment of respiratory tract infections caused by influenza A virus strains. In neurological practice, it is employed as monotherapy in early Parkinson’s disease or as adjunctive therapy with levodopa/carbidopa in more advanced cases. The medication has also shown utility in managing drug-induced extrapyramidal symptoms and fatigue associated with multiple sclerosis, though these are off-label uses requiring careful clinical consideration.
Dosage and direction
For influenza prophylaxis in adults: 200 mg once daily or 100 mg twice daily. For influenza treatment: 200 mg initially, followed by 100 mg daily or 100 mg twice daily. For Parkinson’s disease: Initial dose of 100 mg daily, increasing to 100 mg twice daily after one week if necessary. Maximum recommended dose is 400 mg daily in divided doses. For elderly patients or those with renal impairment, dosage reduction is mandatory. Administration with food may minimize gastrointestinal discomfort. The medication should be taken at consistent times daily to maintain stable plasma concentrations.
Precautions
Renal function must be assessed before initiation and monitored periodically during therapy due to primarily renal elimination. Caution is required in patients with history of seizures, as amantadine may lower seizure threshold. Psychiatric symptoms including depression, anxiety, and hallucinations require careful monitoring, particularly in elderly patients. Patients should avoid abrupt discontinuation to prevent rebound Parkinsonian symptoms. Those with congestive heart failure or peripheral edema require cardiovascular monitoring. Occupational precautions include warning patients about potential dizziness and advising against driving or operating machinery until response is established.
Contraindications
Hypersensitivity to amantadine or any component of the formulation. Severe renal impairment (creatinine clearance <15 mL/min). Pregnancy unless potential benefits outweigh risks. Breastfeeding is contraindicated due to secretion in human milk. Concurrent administration with live attenuated influenza vaccine. Untreated angle-closure glaucoma. History of neuroleptic malignant syndrome. Patients with severe hepatic impairment require extreme caution.
Possible side effect
Common adverse effects include nausea (5-10%), dizziness (5-15%), and dry mouth (5-10%). Neuropsychiatric effects such as insomnia, anxiety, and difficulty concentrating occur in 5-15% of patients. Less frequently, livedo reticularis (mottling of skin) and peripheral edema may develop with long-term use. Serious but rare side effects include neuroleptic malignant syndrome, suicidal ideation, and cardiac arrhythmias. Most side effects are dose-dependent and reversible upon dosage reduction or discontinuation.
Drug interaction
Concomitant use with anticholinergic drugs may potentiate adverse effects. Co-administration with CNS stimulants may increase nervousness and insomnia. QT-prolonging agents may enhance cardiac effects. Memantine should not be co-administered due to similar mechanism. Thiazide diuretics may reduce renal clearance of amantadine. Alcohol may enhance CNS depression effects. Dopamine agonists may have additive therapeutic effects but also increased side effect risk.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. In that case, skip the missed dose and resume the regular schedule. Patients should not double the dose to make up for missed medication. Consistent timing is important for maintaining therapeutic levels, particularly for antiviral prophylaxis. Healthcare providers should be consulted if multiple doses are missed.
Overdose
Symptoms include severe nausea, vomiting, agitation, hallucinations, and cardiac arrhythmias. Management involves gastric lavage if presentation is early, activated charcoal, and supportive care. Acidification of urine may enhance elimination. Hemodialysis may be effective due to the drug’s water solubility and low protein binding. Cardiac monitoring is essential, as fatal arrhythmias have been reported. Specific antidotes are not available.
Storage
Store at controlled room temperature (20-25°C or 68-77°F). Protect from light and moisture. Keep container tightly closed. Do not freeze the oral syrup formulation. Keep out of reach of children and pets. Discard any unused medication after the expiration date. Do not transfer capsules to other containers as this may affect stability.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Healthcare professionals should consult official prescribing information before administering Symmetrel. Individual patient response may vary, and therapeutic decisions should be based on clinical judgment. The manufacturer’s complete prescribing information contains additional details about warnings, precautions, and adverse reactions.
Reviews
Clinical studies demonstrate 70-90% efficacy in influenza A prophylaxis when initiated before exposure. Parkinson’s disease trials show significant improvement in Unified Parkinson’s Disease Rating Scale scores compared to placebo. Long-term observational studies indicate maintained efficacy with appropriate dose titration. Patient-reported outcomes suggest improved quality of life measures in both indications. The medication receives generally favorable expert reviews for its unique mechanism and established safety profile when used appropriately.